BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 10, Issue 34
  • This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (5382)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.
Item 
Count 
PDF230
WORD108
HTML1818
Figures (1-1)545
Tables (1-4)565
 Sum=3266
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse501
Download1615
 Sum=2116
Dec 6, 2022 (publication date) through Jan 15, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Abdulla M, Al Ghareeb AM, Husain HAHY, Mohammed N, Al Qamish J. Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C. World J Clin Cases 2022; 10(34): 12566-12577 [PMID: 36579085 DOI: 10.12998/wjcc.v10.i34.12566]
URL: https://www.wjgnet.com/1948-5182/full/v10/i34/12566.htm
Number Citing Articles
1
Khalid M. Al-Naamani, Heba Omar, Said A. Al Busafi, Halima H. Al Shuaili, Zakariya Al-Naamani, Murtadha Al-Khabori, Elias A. Said, Abdullah H. AlKalbani, B. R. Kamath, Bashar Emad, Shahina Daar, Lolo Alhajri, Alya AlKalbani, Zainab AlFarsi, Haifa Alzuhaibi. Real-World Experience, Effectiveness, and Safety of Direct-Acting Antivirals for the Treatment of Hepatitis C in Oman: A Cross-Sectional, Multicenter Study. Journal of Clinical Medicine 2024; 13(23): 7411 doi: 10.3390/jcm13237411
2
Lynette Goh, Winita Hardikar. Hepatitis C in Children—An Asia–Pacific Concise Perspective. Pathogens 2024; 13(10): 860 doi: 10.3390/pathogens13100860
3
Piotr Rzymski, Aliyu Tijani Jibril, Laila Rahmah, Sunny O. Abarikwu, Fareeda Hashem, Abdullah Al Lawati, Fiona McGowan Martha Morrison, Leander Penaso Marquez, Kawthar Mohamed, Amjad Khan, Saima Mushtaq, Kseniia Minakova, Barbara Poniedziałek, Dorota Zarębska‐Michaluk, Robert Flisiak. Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches. Journal of Medical Virology 2024; 96(9) doi: 10.1002/jmv.29900
4
Engy Mogahed, Haytham Ghita, Afaf Enayet, Noha Yasin, Hanaa El-Karaksy. Generic <i>vs</i> brand forms of direct acting antivirals for hepatitis C virus treatment in Egyptian children. World Journal of Hepatology 2025; 17(12): 110726 doi: 10.4254/wjh.v17.i12.110726
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345